Rmb Capital Management Lowers stake in Danaher Corporation (DHR)

Danaher Corporation (DHR) : Rmb Capital Management reduced its stake in Danaher Corporation by 3.94% during the most recent quarter end. The investment management company now holds a total of 228,001 shares of Danaher Corporation which is valued at $18,463,521 after selling 9,351 shares in Danaher Corporation , the firm said in a disclosure report filed with the SEC on Aug 3, 2016.Danaher Corporation makes up approximately 1.27% of Rmb Capital Management’s portfolio.

Other Hedge Funds, Including , Gratus Capital added DHR to its portfolio by purchasing 77,256 company shares during the most recent quarter which is valued at $6,256,191. Danaher Corporation makes up approx 0.91% of Gratus Capital’s portfolio. Strategic Financial Group added DHR to its portfolio by purchasing 4,667 company shares during the most recent quarter which is valued at $377,934. Danaher Corporation makes up approx 0.22% of Strategic Financial Group’s portfolio. Hedeker Wealth added DHR to its portfolio by purchasing 17,040 company shares during the most recent quarter which is valued at $1,387,738. Danaher Corporation makes up approx 1.17% of Hedeker Wealth’s portfolio. Parametrica Management Ltd added DHR to its portfolio by purchasing 2,631 company shares during the most recent quarter which is valued at $213,742. Danaher Corporation makes up approx 0.31% of Parametrica Management Ltd’s portfolio. Kistler-tiffany Companies added DHR to its portfolio by purchasing 37 company shares during the most recent quarter which is valued at $2,992.

Danaher Corporation closed down -0.22 points or -0.27% at $81.28 with 16,34,579 shares getting traded on Monday. Post opening the session at $81.66, the shares hit an intraday low of $81.2 and an intraday high of $81.7 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.

On the company’s financial health, Danaher Corporation reported $1.25 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 25, 2016. Analyst had a consensus of $1.22. The company had revenue of $5785.00 million for the quarter, compared to analysts expectations of $5766.84 million. The company’s revenue was up 16.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.08 EPS.

Many Wall Street Analysts have commented on Danaher Corporation. Shares were Reiterated by Barclays on Jul 11, 2016 to “Overweight” and Lowered the Price Target to $ 86 from a previous price target of $105 .Danaher Corporation was Initiated by Goldman to “Neutral” on Jul 5, 2016. Danaher Corporation was Upgraded by Bernstein to ” Outperform” on Jun 24, 2016.

Danaher Corporation (Danaher) designs manufactures and markets professional medical industrial and commercial products and services. It operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental and Industrial Technologies. The Test & Measurement segment offers test measurement and monitoring products. The Environmental segment products and services help protect the global water supply facilitate environmental stewardship and enhance the safety of personal data. The Company’s diagnostics business offers analytical instruments reagents consumables software and services. The Dental segment provides products that are used to diagnose treat and prevent disease and ailments of the teeth gums and supporting bone. The Company’s Industrial Technologies solutions help protect the world’s food supply improve packaging design and quality verify pharmaceutical dosages and authenticity and power innovative machines.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Danaher Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Danaher Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.